"I just learned about anti-H in Bombay phenotype patients, and now you're telling me there's an anti-G?"
What Is Anti-G?
Anti-G is an antibody directed against the G antigen of the Rh blood group system. The G antigen is expressed on nearly all red blood cells that are D-positive, C-positive, or both.
That creates an interesting problem in antibody identification.
On a routine antibody screen and panel, anti-G can look essentially identical to a combination of anti-D and anti-C. A patient's plasma may react with D-positive/C-negative cells and with D-negative/C-positive cells, producing what appears to be two separate antibodies when a single anti-G may actually be responsible.
When a panel appears to demonstrate both anti-D and anti-C, several combinations are possible:
anti-D + anti-C
anti-G alone
anti-D + anti-G
anti-C + anti-G
anti-D + anti-C + anti-G
Routine antibody identification generally cannot distinguish among these possibilities because G is associated with both D and C expression.
Does It Matter for Transfusion?
For most transfusion purposes, distinguishing anti-G from anti-D plus anti-C is not particularly important.
A patient with apparent anti-D and anti-C would normally receive red blood cells that are D-negative and C-negative. These units will also lack the G antigen, so they are appropriate whether the patient's antibodies are anti-D, anti-C, anti-G, or some combination of the three.
The distinction becomes much more important during pregnancy.
Why Does Anti-G Matter During Pregnancy?
The major question is whether the patient has formed true alloanti-D.
Consider a D-negative pregnant patient whose antibody panel appears to contain anti-D and anti-C. If further testing shows that the apparent anti-D reactivity is actually caused by anti-G and no immune anti-D is present, that patient remains capable of becoming immunized to the D antigen.
In that situation, the presence of anti-G does not eliminate the indication for Rh immune globulin (RhIG) when RhIG would otherwise be appropriate.
On the other hand, if the patient has already formed immune anti-D, RhIG cannot prevent an alloimmunization that has already occurred and is therefore no longer useful for that purpose.
This is the primary reason that separating anti-G from anti-D can be clinically important in prenatal patients.
Can Anti-G Cause HDFN?
Yes.
Anti-G is an IgG antibody and is capable of crossing the placenta and causing hemolytic disease of the fetus and newborn (HDFN).
Anti-G alone has often been associated with less severe disease than classic anti-D, but it should not be dismissed as harmless. Cases of clinically significant and even severe HDFN requiring intrauterine treatment have been reported with anti-G-containing antibody combinations.
For that reason, antibodies identified during pregnancy should be evaluated according to the patient's clinical situation and the laboratory's maternal antibody monitoring protocols.
Can You Tell Anti-G From Anti-D and Anti-C on a Panel?
Not reliably.
You may occasionally notice differences in reaction strength among D-positive and C-positive panel cells, but reaction strength alone cannot establish whether anti-G, anti-D, or anti-C is present.
Anti-G can coexist with either or both of the other antibodies, antibody strength can vary between reagent cells, and antigen dosage and testing methodology can further complicate the pattern.
So a panel that looks like anti-D + anti-C should not be assumed to contain—or not contain—anti-G based simply on whether one group of cells reacts more strongly than another.
How Do You Differentiate Anti-G From Anti-D and Anti-C?
This is usually a job for an immunohematology reference laboratory.
The classic approach uses differential adsorption and elution with carefully selected red cells:
D-positive, C-negative cells, which express G
D-negative, C-positive cells, which also express G
Sequential adsorption and elution studies can determine whether anti-D and anti-C are truly present and whether anti-G is contributing to the apparent pattern. The procedure is sometimes referred to as a double adsorption/elution because multiple adsorption and elution steps may be required to separate the specificities.
This isn't usually something a routine hospital blood bank performs every day. The testing is labor-intensive, requires appropriately selected cells, and often makes more sense as a reference-laboratory investigation.
The Takeaway
For an ordinary transfusion recipient, differentiating anti-G from anti-D plus anti-C usually does not change red-cell selection: D-negative, C-negative RBCs will also be G-negative.
During pregnancy, however, the distinction can be critical.
A D-negative patient with anti-G but no immune anti-D may still require RhIG prophylaxis. Mistaking anti-G for true anti-D could therefore cause an eligible patient to miss RhIG and subsequently become alloimmunized to D.
So when an apparent anti-D + anti-C pattern shows up in a prenatal patient, anti-G deserves a place on the differential.
0 comments:
Post a Comment